An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tivic Health Announces Key Executive Appointments Strengthening Leadership Team
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Tivic Health Systems (Nasdaq: TIVC) announced key executive appointments, effective April 1, 2022. Veronica Cai becomes Chief Financial Officer, succeeding Briana Benz. Ryan Sabia is promoted to Chief Operating Officer, and Sanjay Ahuja joins as Senior Vice President, Quality Assurance & Regulatory Affairs. Cai brings 25 years of finance experience, while Ahuja has over 25 years in regulatory affairs. CEO Jennifer Ernst emphasizes that their expertise aligns with the company's growth strategy in bioelectronic medicine.
Positive
Appointment of Veronica Cai as CFO adds extensive finance experience to the leadership team.
Ryan Sabia's promotion to COO reflects confidence in his ability to enhance operational efficiency.
Sanjay Ahuja's expertise in regulatory affairs will strengthen compliance and product quality.
Negative
Departure of former CFO Briana Benz might raise concerns about continuity in financial strategy.
Veronica Cai Appointed to Chief Financial Officer; Ryan Sabia Promoted to Chief Operating Officer and Sanjay Ahuja Joined as Senior Vice President, Quality Assurance & Regulatory Affairs
SAN FRANCISCO--(BUSINESS WIRE)--
Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced key executive appointments. Veronica Cai has joined the Company as chief financial officer effective April 1, 2022, Ryan Sabia was promoted to chief operating officer in December 2021, and Sanjay Ahuja, Ph.D. has joined as senior vice president, quality assurance & regulatory affairs. Former chief financial officer, Briana Benz, has stepped down to pursue new opportunities.
Ms. Cai brings 25 years of finance and accounting experience in the medical technology and life sciences industries. Prior to joining the company, Ms. Cai was vice president of accounting and finance at RefleXion Medical, principal accounting officer and corporate controller at Catalyst Bioscience, Inc., director-assistant controller at Zogenix. and senior manager at Ernst & Young.
Mr. Sabia joined the Company last year as vice president of sales and operations, and was promoted to chief operating officer on December 21, 2021. He has almost two decades of experience in scaling global omni-channel logistics and marketplaces, supply chains, systems infrastructures, and sales operations in the medical supply, consumer electronics, health and wellness, and automotive industries. His background includes positions at Fortune 500 companies JP Morgan, BestBuy, and Toyota.
Dr. Ahuja brings over 25 years of extensive experience in global regulatory affairs, clinical affairs, quality, and compliance and has supported a diverse set of regulated therapeutic products including evidence-based pharma, devices and biologics. Before joining the Company, Dr. Ahuja served as vice president of product quality at Intuitive Surgical; vice president of global regulatory and compliance at CooperVision; and senior quality and regulatory leader at ThermoFisher Scientific.
“I’m thrilled to welcome Veronica and Sanjay to our team, and to congratulate Ryan on his promotion to chief operating officer,” said Jennifer Ernst, chief executive officer of Tivic Health. “We believe that their expertise and industry experience in the areas of public company finance, global supply chains, and international regulatory affairs achieve our strategy as we continue to grow our product pipeline in bioelectronic medicine and expand market access and indications for ClearUP®.”
Veronica Cai replaces Briana Benz, who served as chief financial officer through the Company's IPO. "Briana Benz played a critical role in preparing the Company for our initial public offering and in establishing our vision as a public company," said Ms. Ernst. "I am grateful for her contributions and guidance and look forward to her continuing success in her next endeavor."
About Tivic Health
Tivic Health Systems, Inc. is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers choice in the treatment of inflammation and related conditions. For more information visit https://tivichealth.com @TivicHealth
Forward-Looking Statements
This press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Additional information concerning Tivic Health and its business, including a discussion of factors that could materially affect the company operating results, is contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on March 31, 2022, under the heading “Risk Factors,” as well as the Company’s subsequent filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.
Who is the new CFO of Tivic Health as of April 2022?
Veronica Cai has been appointed as the new Chief Financial Officer of Tivic Health effective April 1, 2022.
What is the significance of Veronica Cai's appointment for Tivic Health?
With 25 years of experience in finance, her appointment is expected to enhance Tivic Health's financial strategy and operations.
Who is the new COO of Tivic Health?
Ryan Sabia has been promoted to Chief Operating Officer as of December 2021.
What expertise does Sanjay Ahuja bring to Tivic Health?
Sanjay Ahuja joins as Senior Vice President, Quality Assurance & Regulatory Affairs, bringing over 25 years of experience in regulatory and compliance matters.
What impact might the management changes have on Tivic Health?
The changes are likely to strengthen the leadership team and support the company's growth strategy in bioelectronic medicine.
